Medical Devices & Equipment Company

StomTop Ltd.

8%

Funding Goal $2,000,000
Funding Raised So Far $0
Funding Commitments $150,000
Funding Remaining $1,850,000
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview


StomTop patented devices are based on innovative intestinal sealing, are already in human clinical studies, and are addressing a market estimated at $3 billion annually.

StomTop devices are based on innovative internal intestinal sealing instead of adhesion to the abdomen skin, an impact development aimed to bring relief to millions of Ostomates (people having stoma). StomTop was established by Dr. Nurit Eyal and Dror Eyal, each having more than 30 years of experience in the biotechnology and life sciences industry.

We aim to support the ostomate community in a market of over 2 million cancer and inflammation patients and over $3B in revenue potential. We are targeting a short time to market and a potential deal with a major strategic partner.

SilTop, our first device, is ready for a First in Human clinical study to be started during Q2 2022. StomTop has a submitted broad patent covering the different aspects of our invention and its use.

The current annual market size is estimated at $3B with a CAGR of 5%. The high annual growth is coming from the rising number of colorectal and bladder cancer, inflammatory bowel disease, geriatric population, and living standards in developing countries.

With the funds from the current round, we are planning to take our first device through the process of clinical studies and regulatory market approval, to initiate the development of a device for urostomy, and develop next-generation devices for further ileostomy complications.

On the business side, based on our ongoing discussions with potential strategic partners, we could complete the first deal with one of the leading companies in the field. The potential exit may be from dividends out of substantial milestones payments, royalties, as well as from the acquisition of the company.

Update (6/6/2022): StomTop has just received approval for its first clinical study, beginning in 1 week. This is a key milestone for every health care company.

lock icon

Invest in Company

Sign up or log in now to unlock profile details and access financials, company documents, and invest in companies.

Business Summary


Company Age 3 years, 9 months
Employees 6
Sub-Industry Other Medical Devices & Equipment
Prior Year Revenue
Current Year Revenue
Next Year Revenue

Products/Services


SilTop

StomTop devices are based on a new and innovative concept of internal intestinal sealing instead of adhesion to the abdomen skin. SilTop's unique design provides a leak-proof bag wear experience regardless of stoma or skin conditions, minimizes Peristomal Skin Complications, and enables continuous skincare and treatment while the bag is attached to the stoma.

The device is placed by the ostomate with a user-friendly ergonomic applicator. Placement is clean, easy, and takes less than two minutes (instead of up to one hour with current devices).
SilTop may be replaced everywhere: work, travel, tours, and field conditions - no additional accessories or special environment is required. No more sealant accessories, no messy adhesive placement, and removal. The new devices are designed to be replaced every 2-3 weeks (compared with a twice-weekly and even more in people suffering continuous leaks).

SilTop - our first developed product targets ileostomy patients.

Management


Nurit Eyal
Chief Executive Officer
Nurit E......

Senior Life Sciences Executive & Successful Entrepreneur
Nurit E...... brings over 30 years of experience in senior management positions in the life science industry.
Nurit is a serial entrepreneur who successfully brought a line of products to market and closed strategic partnerships with global corporates. StomTop is her 9th startup. Nurit has held many leading business development roles for international and Israeli companies in the life sciences industry and was the Head of Life Science Investments at 2 VCs.
Nurit is a consultant to the Israeli Innovation Authority, to the Ministry of Economy, and to few European programs.
Nurit holds a Ph.D. from the Weizmann Institute of Science

Kobi Altman
Chief Financial Officer
Kobi A......

Kobi brings over 25 years of experience in senior financial positions in Israeli and US multi-billion corporates.
- He is a member of the Israeli CFO forum
- One of the first investors in the company
- Served as Executive Vice President and Cheif Financial Officer of ICLGroup (NYSE & TASE: ICL)
- Served in a number of senior management positions in Teva Pharmacuticals (NYSE & TASE: TEVA) in the United States and Israel, the latest as Senior Vice President and CFO of the Global Generic Medicins business.
- Served in financial management positions at Amdocs Ltd (NYSE: DOX)
- Holds a B.A. in Economics and Accounting and an M.A. in Economics from Bar-Ilan University and is a certified public accountant.

Dror Eyal
Chief Technology Officer
Dror E......

Senior Pharmaceutical Engineering Executive
Dror has over 30 years of experience in the Biopharmaceutical and Medical Devices Industries. He is specializing in biotech process development, scale-up, manufacturing, and systems engineering & Integration. He served in development and manufacturing executive positions in several pharmaceutical companies, including BTG, Biorest, Valin; in Specsoft, a company that developed CAD tools for the batch process industry; and as a consultant to pharmaceutical and medical devices companies in Israel and abroad.
Dror is an entrepreneur and serial inventor who holds a couple of patents. He is also a technology developer with proven records in many successful projects.

Miki Sahar
Director Quality Assurance
Miki S......

Miki has over 25 years of experience in the field of quality management and regulation, including the establishment of quality systems in Medical Devices companies such as Althera Medical Ltd, FlowMedic, Elan Medical Technologies and others. Miki served also as an Auditor and Project Manager, KEMA Quality B.V. (Dutch Notified Body)
He holds B.Sc. in Aeronautical Engineer from the Technion, M.Sc. In Medical Engineering from Tel Aviv University and an MBA from Manchester University

Malca Chen Zion
Director Physician/Medical Officer
Malca C......

Malca brings over 25 years of experience in the fields of regulation and clinical studies management in medical devices companies, including companies such as Neurovision Optonol, TopSpin, and more.
She holds a Ph.D. from Bar Ilan University.

Omer Shezifi
Chief Engineering
Omer S......

Omer brings 25 years of experience in developing Medical Devices in the fields of Cardio-vascular, Surgical and Endoscopic Devices as an inventor and manager. Omer has more than 20 patents and multi-disciplinary experience ranging from characterization and design, through development, production, clinical studies, regulation, and business development. Omer has held key positions in companies such as Gals Bio Ltd, EndoAid, ARAN Research & Development Ltd., Stryker GI, SightLine Technologies Ltd, and more.
He holds B.Sc. In Mechanical Engineering from the Technion and M.S. Engineering Management from Tufts University, MA, U.S.A.

Investors/Lenders


Individual Investor
Nurit Eyal

Senior Life Sciences Executive & Successful Entrepreneur

Amount
Investment Type
Investment Round
Investment Date
Individual Investor
Dror Eyal

Senior Pharmaceutical Engineering Executive

Amount
Investment Type
Investment Round
Investment Date
Individual Investor
Altman Family

Financial Expert
Chief Financial Officer in international corporate

Amount
Investment Type
Investment Round
Investment Date
Individual Investor
Moshe Eyal

Ostomate over 60 years
Geology Professor

Amount
Investment Type
Investment Round
Investment Date
Angel Group
PipelBiz

Investor Community

Amount
Investment Type
Investment Round
Investment Date

8%

Funding Goal $2,000,000
Funding Raised So Far $0
Funding Commitments $150,000
Funding Remaining $1,850,000
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Documents


Contact


StomTop Ltd.

Nes-Ziona, 7403319, Israel

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan (Optional)
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).